Presentation is loading. Please wait.

Presentation is loading. Please wait.

CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome

Published byКирилл Луцкевич Modified over 5 years ago

Similar presentations

Presentation on theme: "CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome"— Presentation transcript:

1 CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
RESPECTIVE CONTRIBUTION OF TYPE 2 DIABETIC HYPERGLYCEMIA VERSUS THE CLUSTERING OF ABDOMINAL OBESITY-RELATED RISK FACTORS (METABOLIC SYNDROME) TO THE INCREASED CORONARY HEART DISEASE (CHD) RISK IN DIABETES IGT NGT Glycemia 75g OGTT Time CHD RISK Metabolic Syndrome Abdominal Obesity Insulin Resistance Atherogenic Dyslipidemia Impaired Fibrinolysis Pro-thrombotic State Patient with Abdominal Obesity and Type 2 Diabetes Inflammation Increased Blood Pressure

Download ppt "CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome"

Similar presentations

The ABCs of CAD Prevention Gina Ryan, PharmD, BCPS, CDE Clinical Associate Professor Mercer University College of Pharmacy and Health Sciences.

The ABCs of CAD Prevention Gina Ryan, PharmD, BCPS, CDE Clinical Associate Professor Mercer University College of Pharmacy and Health Sciences.
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.

1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference Circulation. 2004;109:433-438.

Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference Circulation. 2004;109:
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Diabetes Mellitus Type 2

Diabetes Mellitus Type 2
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
COMMON LIFESTYLE DISEASES

COMMON LIFESTYLE DISEASES
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)

LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Cardiovascular Disease in Women Module III: Risk Assessment Tool.

Cardiovascular Disease in Women Module III: Risk Assessment Tool.
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.

Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.
Lifestyle Medicine 101 Presented by ACLM Professionals in Training Executive Board 2014.

Lifestyle Medicine 101 Presented by ACLM Professionals in Training Executive Board 2014.
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.

Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
METABOLIC Syndrome: a Global Perspective

METABOLIC Syndrome: a Global Perspective
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.

Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.

Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
STUDY REGARDING THE LIFESTYLE AND EATING HABITS AS RISK FACTORS FOR HEART DISEASE, IN CORONARY PATIENTS FROM THE HEART DISEASE CLINIC II ADULTS UMF Tg-Mures.

STUDY REGARDING THE LIFESTYLE AND EATING HABITS AS RISK FACTORS FOR HEART DISEASE, IN CORONARY PATIENTS FROM THE HEART DISEASE CLINIC II ADULTS UMF Tg-Mures.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.

Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26:2433-41. Centers for Disease Control.

Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.

Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.

Similar presentations

Ads by Google